GELSANA THERAPEUTICS INC

Aurora, CO · Founded 2020 · Biotech · Private

Zwitterionic hydrogel wound dressing that modulates inflammation to promote natural healing

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · gelsanatherapeutics.com

Sector: Biotech
Headquarters: Aurora, CO
Founded: 2020
Latest Form D: $2.5M, Dec 2023
Total capital: $6M

Federal grants: $2.2M; 4 awards · 2023–2024; Rank in peer group#4 of 21
Private capital raised: $2.5M; 1 Form D · last Dec 2023; 35 months since last filing
Federal contracts: $1.3M; 2 awards · Defense; Rank in Biotech#164 of 4373
Granted patents: 0; 3 pending

Capital timeline

Latest events

Sep 2024Federal grantHealth and Human S · Phase I · Advancing Diabetic Foot Ulcer Treatment with Provasliex, a Controlled PDGF Release Hydrogel for Promoting Vascularization and Managing Overactive Inflammation$325K
Mar 2024Federal grantDefense · Phase II · Advancing Military Healthcare: Novel Zwitterionic Hydrogels For Enhanced Wound Healing In Combat-related Burn Injuries$1.2M
Mar 2024Federal contractDefense · Advancing Military Healthcare: Novel Zwitterionic Hydrogels For Enhanced Wound Healing In Combat-related Burn Injuries$1.2M
Dec 2023Private capital raisedForm D · SEC · 1st filing$2.5M
May 2023Federal contractDefense · End-user Exploration Of Novel Zwitterionic Hydrogels For Improved Burn, Blast, And Chronic Wound Healing$75K
Apr 2023Federal grantHealth and Human S · Phase I · Topical Drug Delivery System as an Anti-Inflammatory and Pro-Angiogenic Therapy for Diabetic Wound Healing$300K
Apr 2023Federal grantHealth and Human S · Phase I · Topical Drug Delivery System as an Anti-Inflammatory and Pro-Angiogenic Therapy for Diabetic Wound Healing$300K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

7months

from GELSANA THERAPEUTICS INC’s first federal award to its first private round.

First federal award · Apr 2023: Health and Human S · $300K
First Form D · Dec 2023: $2.5M · 1st Form D
Awards before first raise: 3 awards

An association in public records, not a cause or a prediction.

Standing among 21 peers

Line = median

Biotech · Material

Federal grants#4 · top 19%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Diana VerrilliDirectorNamed in SEC Form D filings
Jim KasicDirectorNamed in SEC Form D filings
Jon FernandezExecutive OfficerNamed in SEC Form D filings
Melissa KrebsExecutive Officer, DirectorNamed in SEC Form D filings
Mike FreemanDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 3

Oct 20, 2022PendingRadical Crosslinked Zwitterionic Gels And Uses ThereofUSPTOApplication 17716538
PendingRadical Crosslinked Zwitterionic Gels And Uses ThereofUSPTOApplication PCTUS2022024048
PendingRadical Crosslinked Zwitterionic Gels And Uses ThereofUSPTOApplication 63173017

GENEINFOSEC INCSimilar federal contract value in Biotech · $1.4M in contracts
BIOO SCIENTIFIC CORPORATIONSimilar federal contract value in Biotech · $1.4M in contracts
GT MOLECULAR, INC.Similar federal contract value in Biotech · $1.3M in contracts
Schrodinger, Inc.Similar federal contract value in Biotech · $1.3M in contracts
OMICRON BIOCHEMICALS, INC.Similar federal contract value in Biotech · $1.3M in contracts
AM BIOTECHNOLOGIES, LLCSimilar federal contract value in Biotech · $1.3M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.